FF EAI Robotics Ecosystem, Inc. (FFR)
0.357
-0.05
(-12.50%)
USD |
NASDAQ |
Nov 20, 16:00
0.3549
0.00 (0.00%)
After-Hours: 20:00
FF EAI Robotics Ecosystem Enterprise Value : 8.679M for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 8.679M |
| November 19, 2026 | 9.818M |
| November 18, 2026 | 9.876M |
| November 17, 2026 | 11.38M |
| November 16, 2026 | 14.78M |
| November 13, 2026 | 17.67M |
| November 12, 2026 | 18.16M |
| November 11, 2026 | 19.46M |
| November 10, 2026 | 20.60M |
| November 09, 2026 | 20.98M |
| November 06, 2026 | 20.60M |
| November 05, 2026 | 18.17M |
| November 04, 2026 | 21.70M |
| November 03, 2026 | 21.82M |
| November 02, 2026 | 23.48M |
| October 30, 2026 | 23.26M |
| October 29, 2026 | 24.15M |
| October 28, 2026 | 26.16M |
| October 27, 2026 | 25.49M |
| October 26, 2026 | 24.60M |
| October 23, 2026 | 25.94M |
| October 22, 2026 | 23.04M |
| October 21, 2026 | 24.82M |
| October 20, 2026 | 24.82M |
| October 19, 2026 | 24.60M |
| Date | Value |
|---|---|
| October 16, 2026 | 26.61M |
| October 15, 2026 | 24.37M |
| October 14, 2026 | 29.73M |
| October 13, 2026 | 33.08M |
| October 12, 2026 | 34.20M |
| October 09, 2026 | 40.90M |
| October 08, 2026 | 40.23M |
| October 07, 2026 | 40.67M |
| October 06, 2026 | 31.52M |
| October 05, 2026 | 25.94M |
| October 02, 2026 | 28.17M |
| October 01, 2026 | 27.95M |
| September 30, 2026 | 29.96M |
| September 29, 2026 | 25.31M |
| September 28, 2026 | 38.46M |
| September 25, 2026 | 39.88M |
| September 24, 2026 | 33.61M |
| September 23, 2026 | 38.46M |
| September 22, 2026 | 33.40M |
| September 21, 2026 | 27.33M |
| September 18, 2026 | 26.93M |
| September 17, 2026 | 25.92M |
| September 16, 2026 | 24.30M |
| September 15, 2026 | 25.61M |
| September 14, 2026 | 28.95M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cibus, Inc. | 377.27M |
| NovelStem International Corp. | 1.983M |
| Oncolytics Biotech, Inc. | 44.27M |
| Sangamo Therapeutics, Inc. | 35.66M |
| Tenax Therapeutics, Inc. | -56.81M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.726M |
| Revenue (Quarterly) | 0.0045M |
| Total Expenses (Quarterly) | 2.731M |
| EPS Diluted (Quarterly) | -0.1311 |
| Gross Profit Margin (Quarterly) | -213.3% |
| Profit Margin (Quarterly) | -60.58K% |
| Earnings Yield | -1.37K% |
| Normalized Earnings Yield | -1389.94 |